Online ISSN:
1945-4589
Editorial Volume 8, Issue 6 pp 1159—1160

Targeting mutant p53 for cancer therapy

Moshe Oren1, , Perry Tal , Varda Rotter ,

  • 1 Department of Molecular Cell Biology, The Weizmann Institute, Rehovot 76100, Israel

Received: June 16, 2016       Published: June 26, 2016      

https://doi.org/10.18632/aging.100992

Copyright: © 2016 et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

View Full Text Download PDF
Corresponding Authors

Moshe Oren
moshe.oren@weizmann.ac.il

Varda Rotter
varda.rotter@weizmann.ac.il

Special Collection on p53
Special Collection
This article is included in:
Special Collection on p53
Keywords
TP53 mutant p53 gain-of-function peptide therapy tumor suppressor MDM2


Copyright © 2025 Rapamycin Press LLC dba Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC